Handelsavisen
prelaunch
Companies Basic Materials 014680.KS
01
014680.KS KRX Specialty Chemicals

Hansol Chemical Co Ltd

$214 500,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,80 %
Op margin
17,2 %
ROE
3,7 %
Net margin
16,0 %
Debt / equity
0,37
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Hansol Chemical Co Ltd is a South Korean specialty chemicals company that produces and sells a range of chemical products, including resins, adhesives, and other industrial chemicals.

Business. Hansol Chemical Co Ltd (014680.KS) is a South Korean specialty chemicals manufacturer operating within the Basic Materials sector. The company is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY15 analysts
15 buy0 hold0 sell
Avg 12m price target344 687,50

Analyst recommendations

15 analysts · consensus Buy
Buy15
Hold0
Sell0
12-month price target
344 687,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
15 analysts · indicative
Ownership
not yet wired
Profitability
3,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 014680.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 014680.KS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Hansol Chemical Co Ltd (014680.KS) is a South Korean specialty chemicals manufacturer operating within the Basic Materials sector. The company is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Hansol Chemical maintains a relatively strong liquidity position, with a current ratio of 1.45, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's net cash position is negative after subtracting total debt, which raises some liquidity concerns. The company's liquidity risk is assessed as medium, suggesting that while it is not in immediate distress, it may face challenges in maintaining liquidity under stress scenarios.

    In terms of profitability, Hansol Chemical's return on equity (ROE) of 3.72% and return on assets (ROA) of 2.23% are below the typical thresholds for high-performing specialty chemical firms. These metrics suggest that the company is generating modest returns relative to its equity and asset base. The company's gross profit margin of 26.8% and operating margin of 17.2% are in line with industry norms, but the net profit margin of 16.0% indicates that the company is effectively managing its operating and non-operating expenses.

    Geographically, Hansol Chemical's revenue is concentrated in South Korea, with a significant portion of its business derived from domestic operations. The company's exposure to a single geographic market increases its vulnerability to local economic and regulatory changes. The company operates in a few key segments, with the majority of its revenue coming from the production and sale of specialty chemicals. There is no significant diversification across product lines or customer bases, which could limit its ability to adapt to market shifts.

    Looking ahead, Hansol Chemical is expected to maintain a stable growth trajectory, with revenue and earnings projected to remain relatively flat in the next fiscal year. The company's capital expenditure of -25.4 billion KRW suggests a reduction in investment in new projects or facilities, which may indicate a focus on cost optimization rather than expansion. The company's free cash flow of 18.7 billion KRW provides some flexibility for dividends or debt reduction, but the lack of significant capital spending may limit long-term growth potential.

    The company's risk profile is characterized by moderate liquidity risk and low dilution risk. The debt-to-equity ratio of 0.37 indicates a conservative capital structure, with a manageable level of leverage. However, the negative net cash position after subtracting total debt suggests that the company may need to access external financing in the future, which could increase its exposure to interest rate and credit risks. The company's dilution risk is assessed as low, with no significant dilution sources identified in recent filings or disclosures.

    Recent events and disclosures indicate that Hansol Chemical has not experienced any major operational or financial disruptions in the near term. The company's recent financial performance has been stable, with consistent revenue and profit figures. Analysts have provided a range of price targets, with a mean of 344,687.50 KRW and a median of 372,500.00 KRW, suggesting a generally positive outlook among market participants. The company has not issued any new shares recently, and there are no indications of upcoming equity offerings or share buybacks.

    Key takeaways
    • Hansol Chemical maintains a conservative capital structure with a debt-to-equity ratio of 0.37, but its net cash position is negative after subtracting total debt.
    • The company's ROE of 3.72% and ROA of 2.23% are below industry benchmarks, indicating modest returns on equity and assets.
    • Revenue and profit are concentrated in South Korea, increasing the company's exposure to local economic and regulatory risks.
    • The company is expected to maintain a stable growth trajectory, with no significant capital expenditures planned in the near term.
    • Analysts have provided a generally positive outlook, with a mean price target of 344,687.50 KRW and a median of 372,500.00 KRW.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 2

    Free cash flow is projected to surge 131.0% year-over-year to 95.1 billion KRW in FY2026.

    Net income is forecast to grow 20.1% year-over-year to 147.3 billion KRW in FY2026.

    BEAR CASE · 5

    The company faces high credit risk, signaling potential difficulties in meeting financial obligations or debt servicing.

    Return on equity of 3.7% trails the 3.9% median for the specialty chemicals peer group.

    Debt-to-equity ratio of 0.37 is higher than the 0.23 median, indicating elevated leverage relative to peers.

    Medium liquidity risk suggests potential challenges in converting assets to cash to meet short-term obligations.

    Revenue CAGR of 3.6% over four years indicates modest top-line growth compared to profit expansion.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-15
    Q1 2026 · Quarter highlights

    Revenue KRW 222.44B, +17,8% YoY; Operating income −23,2% YoY.

    RevenueKRW 222.44B+17,8 % YoY
    Operating incomeKRW 15.44B−23,2 % YoY
    Net incomeKRW 16.51B−28,9 % YoY
    Free cash flowKRW 11.90B−49,4 % YoY
    EPS
    Operating cash flowKRW 200.40B+23,4 % YoY
    Financials
    Income statement
    RevenueKRW 222.44B
    Gross profitKRW 48.78B
    Operating incomeKRW 15.44B
    Net incomeKRW 16.51B
    Margins
    Gross margin21.9%
    Operating margin6.9%
    Net margin7.4%
    FCF margin5.4%
    Balance sheet
    Total assetsKRW 1.60T
    Total liabilitiesKRW 519.86B
    Total equityKRW 1.08T
    Cash & equivalentsKRW 112.55B
    Long-term debtKRW 287.47B
    Cash flow
    Operating cash flowKRW 200.40B
    CapEx-KRW 83.86B
    Free cash flowKRW 11.90B
    SBC
    P&L flow · revenue → net income
    Revenue KRW 222.44BOperating costs KRW 206.99BNet income KRW 16.51B
    Highlights
    • Revenue KRW 222.44B, +17,8% YoY
    • Operating income −23,2% YoY
    • Net income −28,9% YoY
    • Free cash flow −49,4% YoY
    • Net margin 7.4%

    Valuation TTM

    Market price
    $214 500,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $854.77B
    Net cash
    -$169.34B
    Current ratio
    1.4
    Debt / equity
    0.4
    ROA
    2.2%
    ROE
    3.7%
    Cash conversion
    104.0%
    CapEx / revenue
    -12.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    15 895,01
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    15
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-18 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate15 895,01
    Revenueno estimateno estimate1,00T KRW
    Operating incomeno estimateno estimate199,3B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution15 analysts
    Strong buy4
    Buy11
    Hold0
    Sell0
    Strong sell0
    12-month price target$344 687,50 · Median $372 500,00
    Low $162 000,00High $420 000,00
    Operating income · consensus199,3B KRW
    EPS surprise
    −16,0 %
    reported vs consensus · miss
    Revenue surprise
    −11,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$162 000,00
    Mean$344 687,50
    Median$372 500,00
    High$420 000,00
    Spot$214 500,00
    +60.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin17,2 %Above P75
    Net Margin16,1 %Best in class
    ROE3,7 %Below median
    Capex / Rev-12,9 %Below median
    D/E0,37Below median
    Cash Conv1,04Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Hansol Chemical Co Ltd Market data — financials · 2026-05-26
    • Hansol Chemical Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    014680.KSCanonical
    KRX · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-05-15 12:00 UTCEARNINGSQuarterly results — Q1 2026 Revenue KRW 222.44B · Net KRW 16.51B
    2026-03-18 14:12 UTCEARNINGSQuarterly results — Q4 2025 Revenue KRW 230.04B · Net KRW 45.30B
    2026-03-18 14:12 UTCEARNINGSAnnual results — FY 2026 Revenue KRW 883.97B · Net KRW 147.28B
    2025-11-14 07:04 UTCEARNINGSQuarterly results — Q3 2025 Revenue KRW 221.92B · Net KRW 49.07B
    2025-08-14 10:47 UTCEARNINGSQuarterly results — Q2 2025 Revenue KRW 209.57B · Net KRW 36.40B
    2025-05-14 12:05 UTCEARNINGSQuarterly results — Q1 2025 Revenue KRW 188.80B · Net KRW 23.24B
    2025-03-10 13:28 UTCEARNINGSQuarterly results — Q4 2024 Revenue KRW 190.61B · Net KRW 31.25B
    2025-03-10 13:28 UTCEARNINGSAnnual results — FY 2025 Revenue KRW 776.36B · Net KRW 122.68B
    2024-11-13 11:21 UTCEARNINGSQuarterly results — Q3 2024 Revenue KRW 199.08B · Net KRW 36.44B
    2024-08-13 13:22 UTCEARNINGSQuarterly results — Q2 2024 Revenue KRW 197.87B · Net KRW 31.76B
    2024-02-13 13:23 UTCEARNINGSAnnual results — FY 2024 Revenue KRW 771.65B · Net KRW 105.35B
    2023-03-13 13:14 UTCEARNINGSAnnual results — FY 2023 Revenue KRW 885.47B · Net KRW 155.13B
    2022-02-11 10:09 UTCEARNINGSAnnual results — FY 2022 Revenue KRW 768.69B · Net KRW 148.34B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage